| Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality HH Billett, M Reyes-Gil, J Szymanski, K Ikemura, LR Stahl, Y Lo, ... Thrombosis and haemostasis 120 (12), 1691-1699, 2020 | 218 | 2020 |
| Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19) MR Gil, M Barouqa, J Szymanski, JD Gonzalez-Lugo, S Rahman, ... JAMA network open 3 (8), e2017539-e2017539, 2020 | 107 | 2020 |
| Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy SR Panch, J Szymanski, BN Savani, DF Stroncek Biology of Blood and Marrow Transplantation 23 (8), 1241-1249, 2017 | 105 | 2017 |
| Using automated machine learning to predict the mortality of patients with COVID-19: prediction model development study K Ikemura, E Bellin, Y Yagi, H Billett, M Saada, K Simone, L Stahl, ... Journal of medical Internet research 23 (2), e23458, 2021 | 93 | 2021 |
| SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality J Choudhuri, J Carter, R Nelson, K Skalina, M Osterbur-Badhey, ... PloS one 15 (12), e0244777, 2020 | 65 | 2020 |
| Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics N Elavia, SR Panch, A McManus, T Bikkani, J Szymanski, SL Highfill, ... Transfusion 59 (5), 1755-1764, 2019 | 38 | 2019 |
| Hepatic predictors of mortality in severe acute respiratory syndrome coronavirus 2: role of initial aspartate aminotransferase/alanine aminotransferase and preexisting cirrhosis SZ Frager, J Szymanski, JM Schwartz, HS Massoumi, M Kinkhabwala, ... Hepatology Communications 5 (3), 424-433, 2021 | 22 | 2021 |
| ABO blood type association with SARS‐CoV‐2 infection mortality: A single‐center population in New York City J Szymanski, L Mohrmann, J Carter, R Nelson, S Chekuri, A Assa, ... Transfusion 61 (4), 1064-1070, 2021 | 21 | 2021 |
| Laboratory and clinical predictors of 30-day survival for patients on extracorporeal membrane oxygenation (ECMO): 8-year experience at Albert Einstein College of Medicine … IMB Francischetti, J Szymanski, D Rodriguez, M Heo, LR Wolgast Journal of Critical Care 40, 136-144, 2017 | 18 | 2017 |
| Impact of prothrombin complex concentrate on blood use, cost, and outcomes in heart transplantation DW Wu, Y Xia, J Uelinger, S Forest, J Szymanski, K Mohandas, R Walsh, ... The Annals of Thoracic Surgery 105 (4), 1152-1157, 2018 | 16 | 2018 |
| Correlation of coagulation parameters with clinical outcomes during the coronavirus-19 surge in New York: observational cohort M Reyes Gil, JD Gonzalez-Lugo, S Rahman, M Barouqa, J Szymanski, ... Frontiers in Physiology 12, 618929, 2021 | 14 | 2021 |
| Onboarding for pathology residency programs—The Montefiore Experience TM Hébert, J Szymanski, J Mantilla, L McLemore, R Walsh, L Vasovic, ... Academic pathology 3, 2374289516639979, 2016 | 13 | 2016 |
| Breast pathology and mammography BI-RADS category correlation study-a single institute experience S Hu, J Szymanski, Z Khairy, Y Lo, Y Wang Annals of Diagnostic Pathology 35, 11-15, 2018 | 8 | 2018 |
| Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort MR Gil, JD Gonzalez-Lugo, S Rahman, M Barouqa, J Szymanski, ... medRxiv, 2020.05. 01.20087932, 2020 | 6 | 2020 |
| The effect of repeated stimulated granulocyte donations on hematopoietic indexes in donors: a 24‐year donor center experience J Szymanski, J Troendle, S Leitman, H Hong, YY Yau, C Cantilena Transfusion 59 (1), 259-266, 2019 | 5 | 2019 |
| Using automated-machine learning to predict COVID-19 patient survival: identify influential biomarkers K Ikemura, DY Goldstein, J Szymanski, E Bellin, L Stahl, Y Yagi, M Saada, ... medRxiv, 2020.10. 12.20211086, 2020 | 4 | 2020 |
| Treatment‐resistant PLA2R‐negative membranous nephropathy responsive to low‐density lipoprotein apheresis JM Szymanski, M Waldman, C Conry‐Cantilena, KA West Journal of clinical apheresis 34 (4), 495-498, 2019 | 4 | 2019 |
| Continuous platelet transfusion as a potential desensitization regimen in HLA class I alloimmune-mediated platelet refractoriness J Carter, J Szymanski, C Cantilena, S Adams, S Sahu, WA Flegel Blood 130, 4925, 2017 | 4 | 2017 |
| Mysterious clumping in a cell therapy product R Nelson, R Mathews, C Palesi, J Carter, J Szymanski, J Uehlinger, ... Transfusion 61 (8), 2232-2233, 2021 | 3 | 2021 |
| A 50-year-old with gross hematuria LJ Szymanski, JM Szymanski, F Muhletaler, O Alassi Urology 80 (3), 509-511, 2012 | 3 | 2012 |
